DK2086331T3 - Fremgangsmåder til behandling af neuronale lidelser ved anvendelse af MNTF-peptider og analoger deraf. - Google Patents
Fremgangsmåder til behandling af neuronale lidelser ved anvendelse af MNTF-peptider og analoger deraf.Info
- Publication number
- DK2086331T3 DK2086331T3 DK07867451.2T DK07867451T DK2086331T3 DK 2086331 T3 DK2086331 T3 DK 2086331T3 DK 07867451 T DK07867451 T DK 07867451T DK 2086331 T3 DK2086331 T3 DK 2086331T3
- Authority
- DK
- Denmark
- Prior art keywords
- analogs
- methods
- neuronal disorders
- treating neuronal
- mntf peptides
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US85802206P | 2006-11-10 | 2006-11-10 | |
PCT/US2007/023951 WO2008057609A2 (en) | 2006-11-10 | 2007-11-13 | Methods of treating neuronal disorders using mntf peptides and analogs thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2086331T3 true DK2086331T3 (da) | 2013-05-27 |
Family
ID=39365151
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK07867451.2T DK2086331T3 (da) | 2006-11-10 | 2007-11-13 | Fremgangsmåder til behandling af neuronale lidelser ved anvendelse af MNTF-peptider og analoger deraf. |
Country Status (10)
Country | Link |
---|---|
US (1) | US8673852B2 (da) |
EP (1) | EP2086331B1 (da) |
JP (1) | JP5336384B2 (da) |
CN (1) | CN101534648B (da) |
AU (1) | AU2007317730B2 (da) |
CA (1) | CA2669658C (da) |
DK (1) | DK2086331T3 (da) |
ES (1) | ES2407454T3 (da) |
HK (1) | HK1137623A1 (da) |
WO (1) | WO2008057609A2 (da) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101951942B (zh) * | 2008-02-21 | 2014-09-03 | 健能万生物制药公司 | Mntf肽组合物及使用方法 |
NZ600477A (en) * | 2009-12-11 | 2014-07-25 | Univ Case Western Reserve | Insulin analogues with chlorinated amino acids |
GB201015569D0 (en) * | 2010-09-16 | 2010-10-27 | Medical Res Council | Blood assay for prions |
WO2016210123A1 (en) | 2015-06-26 | 2016-12-29 | Genervon Biopharmaceuticals, LLC | Methods of using gm604 in modulating als disease biomarkers leading to prognosis and therapeutic treatment for als disease |
CN110381981A (zh) * | 2016-12-23 | 2019-10-25 | 健能万生物制药公司 | 在诊断和治疗阿尔茨海默病中使用gm6的方法 |
WO2018129421A1 (en) * | 2017-01-09 | 2018-07-12 | Genervon Biopharmaceuticals, LLC | A promising drug candidate for parkinson's disease |
EP3785279A4 (en) * | 2018-05-31 | 2022-07-27 | Immunity Pharma Ltd. | COMPOSITIONS AND METHODS OF USE THEREOF IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6309877B1 (en) * | 1996-09-27 | 2001-10-30 | Km Biotech, Inc. | Polynucleotides encoding motoneuronotrophic factors |
US6841531B2 (en) * | 1996-09-27 | 2005-01-11 | Genervon Biopharmaceuticals Llc | Methods and use of motoneuronotrophic factors |
AU2004205659B2 (en) * | 2003-01-21 | 2009-03-26 | Genervon Biopharmaceuticals Llc | MNTF peptides and compositions and methods of use |
-
2007
- 2007-11-13 EP EP07867451A patent/EP2086331B1/en not_active Not-in-force
- 2007-11-13 WO PCT/US2007/023951 patent/WO2008057609A2/en active Application Filing
- 2007-11-13 CN CN2007800419244A patent/CN101534648B/zh not_active Expired - Fee Related
- 2007-11-13 CA CA2669658A patent/CA2669658C/en not_active Expired - Fee Related
- 2007-11-13 US US11/939,384 patent/US8673852B2/en active Active
- 2007-11-13 ES ES07867451T patent/ES2407454T3/es active Active
- 2007-11-13 JP JP2009536348A patent/JP5336384B2/ja not_active Expired - Fee Related
- 2007-11-13 DK DK07867451.2T patent/DK2086331T3/da active
- 2007-11-13 AU AU2007317730A patent/AU2007317730B2/en not_active Ceased
-
2010
- 2010-03-12 HK HK10102626.6A patent/HK1137623A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US8673852B2 (en) | 2014-03-18 |
EP2086331B1 (en) | 2013-03-27 |
CA2669658C (en) | 2017-12-12 |
AU2007317730B2 (en) | 2014-01-09 |
WO2008057609A8 (en) | 2008-08-28 |
EP2086331A4 (en) | 2010-08-25 |
WO2008057609A2 (en) | 2008-05-15 |
AU2007317730A1 (en) | 2008-05-15 |
US20090048162A1 (en) | 2009-02-19 |
WO2008057609A3 (en) | 2008-12-18 |
JP5336384B2 (ja) | 2013-11-06 |
JP2010509345A (ja) | 2010-03-25 |
EP2086331A2 (en) | 2009-08-12 |
HK1137623A1 (en) | 2010-08-06 |
CN101534648B (zh) | 2013-12-11 |
WO2008057609A4 (en) | 2009-01-29 |
ES2407454T3 (es) | 2013-06-12 |
CN101534648A (zh) | 2009-09-16 |
CA2669658A1 (en) | 2008-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1812110T3 (da) | Apparat til behandling af dermatologiske lidelser | |
DK1948852T3 (da) | Hovedelektrode og fremgangsmåde til dannelse af hovedelektroden | |
DK3689407T3 (da) | Apparat til vejrtrækningshjælp | |
DK2084151T3 (da) | Substituerede dihydropyrazoloner til behandling af kardiovaskulære og hæmatologiske sygdomme | |
DK2781593T3 (da) | Fremgangsmåde til behandling af methanemissioner | |
DK1900693T3 (da) | Indretning til behandling af ballastvand | |
DK2068874T3 (da) | Fremgangsmåder til behandling af multiple myelom med anvendelse af kombinationsterapier baseret på anti-cs1 antistoffer | |
ES2322882B1 (es) | Peptidos inhibidores de la exocitosis neuronal. | |
DK1969099T3 (da) | Fremgangsmåde og indretning til behandling af biomasse | |
DK2240135T3 (da) | Apparat til behandling af fedme og reflukssygdom | |
DK3567035T3 (da) | N-substituerede 2,5-dioxo-azolin-forbindelser til anvendelse ved behandling af cancer | |
DK2001892T3 (da) | Imidazolthiazolforbindelser til behandling af proliferative sygdomme | |
DK2081669T3 (da) | Fremgangsmåde og anordning til fremstilling af granulater | |
EP2083857A4 (en) | METHOD FOR TREATING INTERFERENCE IN CONNECTION WITH MICA | |
DK1720571T3 (da) | Fremgangsmåde til behandling af hæmolytisk sygdom | |
DK1830838T3 (da) | Sammensætninger og fremgangsmåder til behandling af neoplastiske sygdomme | |
DK2046362T3 (da) | Formulering omfattende valleprotein og hydrolysater til forbedring af muskelrekuperation | |
DK2865422T3 (da) | Alpha-msh-derivater til behandling af fotodermatoser | |
DK3403657T3 (da) | Anvendelse af oligouronater til behandling af slimhyperviskositet | |
DK2061485T3 (da) | EV576-peptider til anvendelse ved behandling af Guillain-Barré-syndrom | |
DK2066817T3 (da) | Molekylære afbrydere og fremgangsmåder til anvendelse deraf | |
DK2086331T3 (da) | Fremgangsmåder til behandling af neuronale lidelser ved anvendelse af MNTF-peptider og analoger deraf. | |
DK1994155T3 (da) | Polynukleotider og polypeptidsekvenser involveret i processen for knoglegendannelse. | |
DK2217376T3 (da) | Kuvette og fremgangsmåde til anvendelse af denne kuvette | |
DK2012814T3 (da) | Fremgangsmåder til behandling af autoimmunsygdomme |